Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection.
Fiche publication
Date publication
janvier 2015
Journal
Liver international : official journal of the International Association for the Study of the Liver
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BAUMERT Thomas, Dr HABERSETZER François, Pr MEYER Nicolas
Tous les auteurs :
Habersetzer F, Moenne-Loccoz R, Meyer N, Schvoerer E, Simo-Noumbissie P, Dritsas S, Baumert TF, Doffoël M
Lien Pubmed
Résumé
Hepatitis B surface antigen (HBsAg) clearance is the main indicator of viral cure in patients infected with the hepatitis B virus (HBV). We sought to identify the parameters associated with HBsAg loss in a well-characterized real-life clinical cohort of chronically HBV-infected patients.
Mots clés
Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Antiviral Agents, therapeutic use, Carrier State, diagnosis, Cohort Studies, Female, France, Hepatitis B Surface Antigens, blood, Hepatitis B, Chronic, diagnosis, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prospective Studies
Référence
Liver Int.. 2015 Jan;35(1):130-9